Lauric acid and myristic acid from Allium sativum inhibit the growth of Mycobacterium tuberculosis H37Ra: in silico analysis reveals possible binding to protein … R Muniyan, J Gurunathan Pharmaceutical Biology 54 (12), 2814-2821, 2016 | 35 | 2016 |
Latent tuberculosis: interaction of virulence factors in Mycobacterium tuberculosis S Sundararajan, R Muniyan Molecular Biology Reports 48 (8), 6181-6196, 2021 | 28 | 2021 |
Favorable binding of Quercetin to α-Synuclein as potential target in Parkinson disease: An Insilico approach HS Baul, M Rajiniraja Research journal of pharmacy and technology 11 (1), 203-206, 2018 | 22 | 2018 |
Genetic alterations and clinical dimensions of oral cancer: a review K Karunakaran, R Muniyan Molecular Biology Reports 47 (11), 9135-9148, 2020 | 18 | 2020 |
Molecular Docking Studies of Selected Flavonoids on Inducible Nitric Oxide Synthase (INOS) in Parkinson’s Disease HS Baul, R Muniyan Research journal of pharmacy and technology 11 (8), 2018 | 14 | 2018 |
Andrographis paniculata leaf extracts as potential Naja naja anti-snake venom A Sivakumar, A Manikandan, M Rajini Raja, G Jayaraman World J Pharma Pharm Sci 4 (12), 1036-1050, 2015 | 11 | 2015 |
Bioautography guided screening of selected Indian medicinal plants reveals potent antimycobacterial activity of Allium sativum extracts-implication of non-sulfur compounds in … M Rajiniraja, G Jayaraman Int J Pharm Pharm Sci 6, 671-676, 2014 | 11 | 2014 |
MIA-QSAR based model for bioactivity prediction of flavonoid derivatives as acetylcholinesterase inhibitors P Muthukumaran, M Rajiniraja Journal of Theoretical Biology 459, 103-110, 2018 | 9 | 2018 |
Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors P Muthukumaran, M Rajiniraja Journal of Theoretical Biology 469, 18-24, 2019 | 8 | 2019 |
Review on the extension of shelf life for fruits and vegetables using natural preservatives U Venkatesan, R Muniyan Food Science and Biotechnology, 1-20, 2024 | 7 | 2024 |
Identification of allosteric inhibitor against AKT1 through structure-based virtual screening K Karunakaran, R Muniyan Molecular Diversity 27 (6), 2803-2822, 2023 | 7 | 2023 |
Mechanistic study of the inhibition of monoamine oxidase-B by quercetin as the potential therapeutic strategy for Parkinson’s Disease: An in silico approach HS Baul, M Rajiniraja Journal of Computational Methods in Sciences and Engineering, 1-7, 2018 | 7 | 2018 |
Antimycobacterial activity of potential plant metabolites with emphasis on management of drug resistant Mycobacterium tuberculosis strains R Muniyan, J Gurunathan Res J Biotechnol 12, 12, 2017 | 7 | 2017 |
In silico binding study of bioactive Hispolon and its Analogues to mycobacterial mtfabH P Muthukumaran, M Rajiniraja Research Journal of Pharmacy and Technology 10 (7), 2229-2232, 2017 | 5 | 2017 |
Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis S Sundararajan, K Karunakaran, R Muniyan Journal of Biomolecular Structure and Dynamics 42 (12), 6280-6291, 2024 | 4 | 2024 |
Prediction of alternate drugs for Crizotinib resistant mutated-ALK inhibitors in lung cancer treatment: an In Silico approach M Rajiniraja Research Journal of Pharmacy and Technology 13 (8), 3643-3647, 2020 | 3 | 2020 |
In vitro inhibition potential of mono‐n‐octyl phthalate on Mycobacterium tuberculosis H37Ra: Possibility of binding to mycobacterial PknB—An in silico approach M Rajiniraja, A Sivaramakrishna, V Sabareesh, G Jayaraman Biotechnology and Applied Biochemistry 65 (6), 865-875, 2018 | 3 | 2018 |
Protein-Protein Interaction of Mutated Agouti Signaling Protein (ASIP) to Melanocortin Receptor 1 (MC1R) in Melanoma Skin Cancer: An Insilico Study K Karunakaran, JR Malaiyappan, R Muniyan Research journal of pharmacy and technology 11 (9), 2018 | 3 | 2018 |
Pharmacophore-guided in-silico discovery of SIRT1 inhibitors for targeted cancer therapy D Sharma, R Muniyan Computational Biology and Chemistry 113, 108275, 2024 | 2 | 2024 |
Computational identification of potential tau tubulin kinase 1 (TTBK1) inhibitors: a structural analog approach K Purushothaman, E Sivasankar, M Krishnamoorthy, K Karunakaran, ... In Silico Pharmacology 12 (2), 66, 2024 | 2 | 2024 |